Soluble CXCL16 in Preoperative Serum is a Novel Prognostic Marker and Predicts Recurrence of Liver Metastases in Colorectal Cancer Patients

Stromal CXCR4 and CXCL12 Expression is Associated with Distant Recurrence and Poor Prognosis in Rectal Cancer After Chemoradiotherapy

(2010) Susumu Saigusa et al.   ANNALS OF SURGICAL ONCOLOGY

KAP1 Is Associated With Peritoneal Carcinomatosis in Gastric Cancer

(2009) Takeshi Yokoe et al.   ANNALS OF SURGICAL ONCOLOGY

Role of CXCR4/SDF-1α in the migratory phenotype of hepatoma cells that have undergone epithelial–mesenchymal transition in response to the transforming growth factor-β

(2009) Esther Bertran et al.   CELLULAR SIGNALLING

The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma

(2008) Federica Marchesi et al.   CANCER RESEARCH

CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway

(2008) J. Wang et al.   CANCER RESEARCH

CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells

(2008) Weidong Hu et al.   CANCER SCIENCE

Systemic Inflammatory Response Predicts Prognosis in Patients with Advanced-Stage Colorectal Cancer

(2008) Rohini Sharma et al.   Clinical Colorectal Cancer

Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients

(2008) Paul Gutwein et al.   EUROPEAN JOURNAL OF CANCER

CXCL16 Functions as a Novel Chemotactic Factor for Prostate Cancer Cells In vitro

(2008) Y. Lu et al.   MOLECULAR CANCER RESEARCH